kathimerini.gr

Long COVID: Prevalence, Causes, and Long-Term Impacts

Long COVID, affecting 6-11% of COVID-19 patients, involves symptoms lasting over three months; research is ongoing to understand causes (potentially persistent virus or inflammation), effective treatments, and long-term impacts.

Read original article in Greek

Greek

Greece

HealthScienceGlobal HealthMedical ResearchLong CovidSars-Cov-2Post-Covid-19Health Implications

CdcMassachusetts General HospitalHarvard

Michael Vanelzakker

What are the suspected causes of long COVID, considering the variability in symptoms and patient backgrounds?: The diverse nature of long COVID symptoms, ranging from mild fatigue to severe organ damage, complicates research. While some long COVID cases may result from persistent viral presence or inflammation, other cases might stem from initial infection severity and pre-existing conditions.
What is the prevalence and range of symptoms associated with long COVID, and what are the immediate implications for public health?: Long COVID, defined as symptoms lasting at least three months post-SARS-CoV-2 infection, affects 6-11% of adults who have had COVID-19, according to the US Centers for Disease Control and Prevention. Symptoms vary widely, including fatigue, brain fog, shortness of breath, and others, hindering research into causes and treatments.
What are the long-term health consequences of long COVID, and what research directions are being pursued to address its treatment and prevention?: Research into long COVID is still ongoing, with studies exploring various treatment avenues, including immunotherapies and antiviral approaches. Identifying individuals at higher risk and developing early interventions are key priorities, as the long-term consequences of long COVID and its potential links to worsening chronic diseases remain uncertain.

Cognitive Concepts

2/5

Framing Bias

The framing is largely neutral. The questions are straightforward, and Dr. VanElzakker's answers are presented without overt editorial slant. However, the selection of questions might subtly emphasize the uncertainty surrounding Long COVID, potentially downplaying the severity of the condition for some readers.

3/5

Bias by Omission

The article focuses primarily on the experiences and perspectives of Dr. VanElzakker, a neurologist and Long COVID researcher. While this provides valuable insight, it might omit other perspectives, such as those of patients with diverse Long COVID experiences or researchers from different fields. The article also doesn't discuss preventative measures beyond general COVID-19 prevention.

Sustainable Development Goals

Good Health and Well-being Negative

Direct Relevance

The article discusses Long COVID, a condition affecting 6-11% of adults who have had COVID-19, causing various long-term symptoms and potentially exacerbating pre-existing conditions. This negatively impacts the SDG on Good Health and Well-being by increasing the burden of disease and long-term health complications.

Feb 22, 01:09

Liquid Biopsies: Revolutionizing Cancer Treatment

Liquid biopsies, blood tests detecting tumor traces, are transforming cancer treatment by enabling earlier detection and personalized therapies; however, high costs and complex analysis limit widespread adoption in Spain, where their use is most advanced in lung, colon, and rectal cancers.

Feb 22, 13:09

Leucovorin Shows Promise for Autism Treatment

Off-label use of the prescription drug leucovorin shows promise in improving communication in some autistic children, prompting research to seek FDA approval for wider use and insurance coverage, although larger studies are needed to confirm its effectiveness and safety across different autistic populations.

Feb 22, 10:06

Global Anxiety Surge Linked to Modern Lifestyles and Economic Instability

A study links the global surge in anxiety disorders to demanding lifestyles, economic instability, and the constant connectivity of modern life, emphasizing the need for early psychological intervention to prevent long-term consequences like agoraphobia.

Feb 21, 13:08

Gene Therapy Restores Sight in Children with Inherited Blindness

London scientists successfully treated childhood blindness caused by Leber Congenital Amaurosis (LCA) in four children (ages 1-2) from Turkey, Tunisia, and the USA using a groundbreaking gene therapy that involved a 60-minute laparoscopic surgery to inject healthy AIPL1 genes into their retinas, resulting in improved vision including object recognition, and even reading and writing in some cases, as published in The Lancet.